These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37081214)

  • 1. The AAPS Journal Theme Issue: Compendium of Immunogenicity Risk Assessments: an Industry Guidance Built on Experience and Published Work.
    Mora JR; Richards SM
    AAPS J; 2023 Apr; 25(3):43. PubMed ID: 37081214
    [No Abstract]   [Full Text] [Related]  

  • 2. Report on the AAPS Immunogenicity Guidance Forum.
    Myler H; Gorovits B; Phillips K; Devanarayan V; Clements-Egan A; Gunn GR; Kirshner S; DeSilva B; Shah VP
    AAPS J; 2019 Apr; 21(4):55. PubMed ID: 30993501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AAPS Journal Theme Issue: Rising Stars in Drug Delivery and Novel Carriers.
    Salem AK; Nguyen J; Ainslie KM
    AAPS J; 2022 Apr; 24(3):51. PubMed ID: 35381891
    [No Abstract]   [Full Text] [Related]  

  • 4. The AAPS Journal Theme Issue: "Perspectives on Clinical Drug Development of Long-Acting Injectables".
    T'jollyn H; Ackaert O
    AAPS J; 2023 Nov; 25(6):104. PubMed ID: 37963990
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicine and medical sciences in Africa.
    Gathiram P; Hänninen O
    Pathophysiology; 2014 Jun; 21(2):129-33. PubMed ID: 24290618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: "Drug Products, Including Biological Products, that Contain Nanomaterials".
    de Vlieger JSB; Crommelin DJA; Tyner K; Drummond DC; Jiang W; McNeil SE; Neervannan S; Crist RM; Shah VP
    AAPS J; 2019 Apr; 21(4):56. PubMed ID: 30997588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scientific impact of presentations from the EURAPS and the AAPS meetings: A 10-year review.
    Khorasani H; Lassen MH; Kuzon W; Bonde C
    J Plast Reconstr Aesthet Surg; 2017 Jan; 70(1):31-36. PubMed ID: 27818149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental tobacco smoke research published in the journal Indoor and Built Environment and associations with the tobacco industry.
    Garne D; Watson M; Chapman S; Byrne F
    Lancet; 2005 Feb 26-Mar 4; 365(9461):804-9. PubMed ID: 15733724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical Quality, Team Science, and Education Themes: Observations and Commentary on a Remarkable AAPS PharmSciTech Theme Issue.
    Hussain AS; Morris K; Gurvich VJ
    AAPS PharmSciTech; 2021 Mar; 22(3):88. PubMed ID: 33665776
    [No Abstract]   [Full Text] [Related]  

  • 10. New FDA draft guidance on immunogenicity.
    Parenky A; Myler H; Amaravadi L; Bechtold-Peters K; Rosenberg A; Kirshner S; Quarmby V
    AAPS J; 2014 May; 16(3):499-503. PubMed ID: 24682766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GRACE Checklist: A Validated Assessment Tool for High Quality Observational Studies of Comparative Effectiveness.
    Dreyer NA; Bryant A; Velentgas P
    J Manag Care Spec Pharm; 2016 Oct; 22(10):1107-13. PubMed ID: 27668559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of confirmation cut point discussions.
    Smith HW; Moxness M; Marsden R
    AAPS J; 2011 Jun; 13(2):227-9. PubMed ID: 21380610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison on chemical features and antioxidant activity of polysaccharides from Auricularia auricula by three different enzymes.
    Xiao B; Huang Q; Chen S; Yao J; Zeng J; Shen J; Wang G; Wang W; Zhang Y
    J Food Biochem; 2022 May; 46(5):e14051. PubMed ID: 35142368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on the draft ICH-M10 guidance: an interview with Mark Arnold.
    Arnold ME
    Bioanalysis; 2019 Aug; 11(15):1379-1382. PubMed ID: 31490110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2012 AAPS National Biotech Conference Open Forum: a perspective on the current state of immunogenicity prediction and risk management.
    Rajadhyaksha M; Subramanyam M; Rup B
    AAPS J; 2013 Oct; 15(4):1155-9. PubMed ID: 23990501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Close Are We to Profiling Immunogenicity Risk Using In Silico Algorithms and In Vitro Methods?: an Industry Perspective.
    Gokemeijer J; Jawa V; Mitra-Kaushik S
    AAPS J; 2017 Nov; 19(6):1587-1592. PubMed ID: 28971356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Sources of Funding That Contribute to Scholastic Productivity in Academic Plastic Surgeons.
    Ruan QZ; Cohen JB; Baek Y; Chen AD; Doval AF; Singhal D; Fukudome EY; Lin SJ; Lee BT
    Ann Plast Surg; 2018 Apr; 80(4 Suppl 4):S214-S218. PubMed ID: 29319573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
    J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Asthma Action Plans: National Cross-Sectional Online Survey of Parents' Perceptions.
    Pletta KH; Kerr BR; Eickhoff JC; Allen GS; Jain SR; Moreno MA
    JMIR Pediatr Parent; 2020 Nov; 3(2):e21863. PubMed ID: 33164900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on the draft ICH-M10 guidance: an interview with Boris Gorovits.
    Gorovits B
    Bioanalysis; 2019 Aug; 11(15):1383-1385. PubMed ID: 31490105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.